Abstract
Polyarteritis nodosa is a systemic vasculitis that involves predominantly medium-sized vessels. In 1852,Rokitansky described a man who presented with fever, abdominal pain, and bloody diarrhea, and shortly thereafter expired. Autopsy findings included small aneurysms of the arterial system, sparing the arteries of the brain and the large arteries. The aneurysms were identified as inflammatory and the disease was named periarteritis nodosa by Kussmaul and Maier in 1866. The term polyarteritis nodosa was introduced by Ferrari in 1903 to emphasize the transmural inflammation that characterizes this vasculitis (1). Because polyarteritis nodosa has overlapping features with other forms of systemic vasculitis, the nosology has been confusing. Interpretation of data from case series in the literature is difficult because many series are comprised of patients now regarded as having had different diseases. This summary of polyarteritis nodosa will describe the disease in its classic form and briefly discuss the other entities that may have a similar pattern of vasculitis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Matteson EL. Historical perspective of vasculitis: polyarteritis nodosa and microscopic polyangiitis. Curr Rheum Rep 2002;4:67–74.
Bonsib SM. Polyarteritis nodosa. Semin Diag Pathol 2001;18:14–23.
Stone JH. Polyarteritis nodosa. JAMA 2002;288:1632–1639.
Soufir N, Descamps V, Crickx B, et al. Hepatitis C virus infection in cutaneous polyarteritis nodosa: A retrospective study of 16 cases. Arch Dermatol 1999;135:1001–1002.
Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: A clinicopathological study of 79 cases. Br J Dermatol 1997;136:706–713.
Calabrese LH, Estes M, Yen-Lieberman B, et al. Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis Rheum 1989;32:569–576.
Rodriguez P, Suarez P, del Rio E, et al. Cutaneous granulomatous vasculitis after herpes zoster infection showing polyarteritis nodosa-like features. Clin Exp Dermatol 1997;22:274–276.
Elkon KB, Hughes GR, Catovsky D, et al. Hairy-cell leukaemia with polyarteritis nodosa. Lancet 1979;i:678.
Burke, AP, Virmani R. Localized vasculitis. Semin Diag Pathol 2001;18:59–66.
Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990;33:1074–1087.
Lightfoot RW, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088–1093.
Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187–192.
Agard C, Mouthon L, Mahr A, Guillevin L. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start? Arthritis Rheum 2003;49:709–715.
Chanseaud Y, Pena-Lefebvre PG, Guilpain P, et al. IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small-and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. Clin Immunol 2003;109:165–178.
Hughes LB, Bridges SL. Polyarteritis nodosa and microscopic polyangiitis: Etiologic and diagnostic considerations. Curr Rheum Reports 2002;4:75–82.
Crotty CP, DeRemee, Winkelmann RK. Cutaneous clinicopathologic correlation of allergic granulomatosis. J Am Acad Dermatol 1981;5:571–581.
Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:1512–1523.
Seo P, Stone JH. The antineutrophil cytoplasmic antibodyassociated vasculitides. Am J Med 2004;117:39–50.
Albert DA, Rimon D, Silverstein MD. The diagnosis of polyarteritis nodosa, I: A literature-based decision analysis approach. Arthritis Rheum 1988;31:1117–1127.
Albert DA, Silverstein MD, Paunicka K, Reddy G, Chang RW, Derus C. The diagnosis of polyarteritis nodosa, II: Empirical verification of a decision analysis model. Arthritis Rheum 1988;31:1128–1134.
Lam KC, Lai CL, Trepo C, Wu PC. Deleterious effects of prednisolone in hepatitis B surface antigen-positive chronic active hepatitis. N Engl J Med 1981;304:380–386.
Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: A prospective study in 342 patients. Medicine 1996;75:17–28.
Guillevin L, Cohen P, Mahr, et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003;49:93–100.
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
(2007). Polyarteritis Nodosa. In: Deadly Dermatologic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68858-9_37
Download citation
DOI: https://doi.org/10.1007/978-0-387-68858-9_37
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-25442-5
Online ISBN: 978-0-387-68858-9
eBook Packages: MedicineMedicine (R0)